Free Cash Flow for Thermo Fisher Scientific (TMO)
Free Cash Flow for Thermo Fisher Scientific (TMO): headline value $6.75B · YoY -13.4%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingFree Cash FlowSwitch metric
Latest period
$6.75B
YoY change
-13.4%
5Y CAGR
-1.6%
Peak year (2024)
$7.27B
Latest annual
$6.29B
Free Cash Flow history chart for Thermo Fisher Scientific (TMO) from 1989 to 2025
Free Cash Flow history table for Thermo Fisher Scientific (TMO) from 1989 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $6.29B | -13.4% | ||
| 2024 | $7.27B | +4.9% | ||
| 2023 | $6.93B | +0.2% | ||
| 2022 | $6.91B | -1.6% | ||
| 2021 | $7.02B | +3.0% | ||
| 2020 | $6.82B | +68.4% | ||
| 2019 | $4.05B | +6.9% | ||
| 2018 | $3.79B | +8.2% | ||
| 2017 | $3.50B | +29.0% | ||
| 2016 | $2.71B | +13.3% | ||
| 2015 | $2.39B | +9.2% | ||
| 2014 | $2.19B | +26.8% | ||
| 2013 | $1.73B | +0.2% | ||
| 2012 | $1.72B | +21.1% | ||
| 2011 | $1.42B | +15.6% | ||
| 2010 | $1.23B | -15.1% | ||
| 2009 | $1.45B | +25.6% | ||
| 2008 | $1.16B | -11.6% | ||
| 2007 | $1.31B | +297.7% | ||
| 2006 | $328.86M | +44.6% | ||
| 2005 | $227.37M | +6.0% | ||
| 2004 | $214.53M | +25.8% | ||
| 2003 | $170.58M | +230.1% | ||
| 2002 | $51.68M | -50.1% | ||
| 2001 | $103.60M | -17.7% | ||
| 2000 | $125.88M | -183.4% | ||
| 1999 | -$150.88M | +107.5% | ||
| 1998 | -$72.70M | -89.5% | ||
| 1997 | -$691.70M | -791.7% | ||
| 1996 | $100.00M | -24.1% | ||
| 1995 | $131.70M | -8.5% | ||
| 1994 | $144.00M | +105.4% | ||
| 1993 | $70.10M | -1474.5% | ||
| 1992 | -$5.10M | -51.4% | ||
| 1991 | -$10.50M | -89.6% | ||
| 1990 | -$101.40M | +33700.0% | ||
| 1989 | -$300,000 | — |
Free Cash Flow values are taken from Thermo Fisher Scientific's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Thermo Fisher Scientific (TMO) reported free cash flow of $6.29B – declined 13.4% year-over-year.
Thermo Fisher Scientific free cash flow has contracted on net over the period, with a -1.6% compound annual growth rate over 2020–2025 (5 years).
Thermo Fisher Scientific free cash flow peaked at $7.27B in 2024; the latest annual figure is $6.29B in 2025 (13.4% below peak).
Across the available history, free cash flow reached its high of $7.27B in 2024 and its low of -$691.70M in 1997.
Among 8 Healthcare peers, Thermo Fisher Scientific (TMO) ranks 9th; the peer median for free cash flow is $14.22B.
Thermo Fisher Scientific Free Cash Flow by Year
Thermo Fisher Scientific Free Cash Flow 2025: $6.29B
Thermo Fisher Scientific free cash flow in 2025 was $6.29B, declined 13.4% below 2024.
Thermo Fisher Scientific Free Cash Flow 2024: $7.27B
Thermo Fisher Scientific free cash flow in 2024 was $7.27B, edged up 4.9% from 2023. This figure represents the highest annual value in the available history.
Thermo Fisher Scientific Free Cash Flow 2023: $6.93B
Thermo Fisher Scientific free cash flow in 2023 was $6.93B, edged up 0.2% from 2022.
Thermo Fisher Scientific Free Cash Flow 2022: $6.91B
Thermo Fisher Scientific free cash flow in 2022 was $6.91B, edged down 1.6% below 2021.
Thermo Fisher Scientific Free Cash Flow 2021: $7.02B
Thermo Fisher Scientific free cash flow in 2021 was $7.02B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers — Free Cash Flow
Companies in the same sector as Thermo Fisher Scientific, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is Thermo Fisher Scientific's free cash flow?
Latest reported free cash flow for Thermo Fisher Scientific (TMO) is $6.75B (period ending March 28, 2026).
How has Thermo Fisher Scientific free cash flow changed year-over-year?
Thermo Fisher Scientific (TMO) free cash flow changed -13.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Thermo Fisher Scientific free cash flow?
Thermo Fisher Scientific (TMO) free cash flow compound annual growth rate is -1.6% over the most recent 5 years available.
When did Thermo Fisher Scientific free cash flow hit its highest annual value?
Thermo Fisher Scientific free cash flow reached its highest annual value of $7.27B in 2024.
What was Thermo Fisher Scientific free cash flow in 2024?
Thermo Fisher Scientific (TMO) free cash flow in 2024 was $7.27B.
What was Thermo Fisher Scientific free cash flow in 2025?
Thermo Fisher Scientific (TMO) free cash flow in 2025 was $6.29B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
TMO Overview
Company profile, financial tools, and key metrics
TMO Revenue Counter
Earns $1,433 every second. See per minute, hour, and day.
TMO Earnings Counter
Earns $217.50 per second net profit. See per minute, hour, and day.
TMO Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
TMO What If Invested
What if you had invested $1,000? See historical returns from any date.
TMO How It Makes Money
Discover visual breakdown of $45.20B in revenue — where it comes from and where it goes.
TMO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TMO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TMO Daily Price Character
Balanced · 47.1% historical win rate (green days). Streaks & record days.
TMO Buybacks
4.54% TTM buyback yield. Shareholder yield & SBC comparison.
TMO Stock Split History
8 splits on record. Dates, ratios, and cumulative multiple.
TMO Dividend Profile
Yield: 0.38%. Safety: 5/8. See full history.
TMO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TMO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.